Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EYPT stock hub

EyePoint, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EYPTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EYPT

In the news

Latest news · EYPT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-102.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-1,059.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EYPT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001314102
Company name	EyePoint, Inc.
Country	United States
Country code	US
Cusip	30233G209
Employees	214
Employees Change	49%
Employees Change Percent	29.7
Enterprise value	$945.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2005-01-27
Isin	US30233G2093
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$13.66
Price currency	USD
Rev Per Employee	35,579.44x
Sector	Healthcare
Sic	3826
Symbol	EYPT
Website	https://eyepoint.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.71%
EV Sales Forward	1,187.36x
EV/Sales	124.13x
P/B ratio	5.1x
P/S ratio	150.42x
PS Forward	1,438.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-224.8M
Net Income	$-271.6M
Net Income Growth Years	0%
Pretax Margin	-3,564.09%
Profit Per Employee	$-1.3M
ROA	-54.13
Roa5y	-24.33
ROCE	-112.4
ROE	-102.7
Roe5y	-57.01
ROIC	-1,059.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.16%
Cagr15y	-7.21%
Cagr1y	124.43%
Cagr3y	27.82%
Cagr5y	7%
EPS Growth Years	0
Revenue Growth	-86.41x
Revenue Growth Q	-97.15x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.38x
Revenue Growth5 Y	-25.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$288.2M
Cash	$222.5M
Current Assets	$249.5M
Current Liabilities	$37.5M
Debt	$22.4M
Debt Equity	$0.1
Equity	$230.5M
Interest Coverage	-8,540.1
Liabilities	$57.7M
Long Term Assets	$38.7M
Long Term Liabilities	$20.3M
Net Cash	$200.1M
Net Cash By Market Cap	$17.47
Net Cash Growth	-31.96%
Net Debt Equity	$-0.87
Tangible Book Value	$230.5M
Tangible Book Value Per Share	$2.68
WACC	13.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.66
Inventory Turnover	137.6
Net Working Capital	$-8.3M
Quick ratio	5.97
Working Capital	$212M
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.76%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.4%
1Y total return	124.3%
200-day SMA	13.84
3Y total return	108.87%
50-day SMA	14.16
50-day SMA vs 200-day SMA	50over200
5Y total return	40.25%
All Time High	72.2
All Time High Change	-81.08%
All Time High Date	2010-12-22
All Time Low	2.19
All Time Low Change	523.74%
All Time Low Date	2022-12-16
ATR	0.76
Beta	1.77
Beta1y	1.93
Beta2y	1.89
Ch YTD	-25.23
High	13.75
High52	19.11
High52 Date	2025-12-08
High52ch	-28.52%
Low	13.29
Low52	5.3
Low52 Date	2025-05-14
Low52ch	157.74%
Ma50ch	-3.56%
Premarket Change Percent	1.19
Premarket Price	$13.57
Premarket Volume	1,294
Price vs 200-day SMA	-1.26%
RSI	48.35
RSI Monthly	52.62
RSI Weekly	49.02
Sharpe ratio	1.44x
Sortino ratio	2.53
Total Return	-27.76%
Tr YTD	-25.23
Tr15y	-67.48%
Tr1m	0.66%
Tr1w	2.4%
Tr3m	2.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$27.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.8
Earnings Revenue Estimate	342,264x
Earnings Revenue Estimate Growth	-98.6x
Operating Income	$-281.8M
Operating margin	-3,701.4
Price target	$31.4
Price Target Change	$130
Price Target Change Top	$101

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58,010,736%
Float Percent	69.19%
Shares Insiders	0.95%
Shares Institutions	71.05%
Shares Out	83,841,298
Shares Qo Q	3.57%
Shares Yo Y	27.76%
Short Float	23.55%
Short Ratio	14.69
Short Shares	16.29

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	868,774.65x
Bv Per Share	2.68
Ch10y	-52.4
Ch15y	-67.48
Ch1m	0.66
Ch1w	2.4
Ch1y	124.3
Ch3m	2.71
Ch3y	108.9
Ch5y	40.25
Ch6m	21.86
Change	1.86%
Change From Open	2.32
Close	13.41
Days Gap	-0.45
Depreciation Amortization	2,389,250
Dollar Volume	9,036,568.1
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$-281.8M
EBITDA	$-279.4M
EPS	$-3.51
F Score	0
Fiscal Year End	December
Founded	1,987
Income Tax	$229,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2020-12-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	14.45
Ma150ch	-5.45%
Ma20	13.94
Ma20ch	-1.99%
Next Earnings Date	2026-08-05
Open	13.35
Optionable	Yes
Position In Range	80.43
Ppne	19,777,000
Pre Close	13.41
Price Date	2026-05-08
Ptbv Ratio	4.97
Relative Volume	0.76x
Revenue	7,614,000x
Tax By Revenue	3.01x
Tr6m	21.86%
Us State	Massachusetts
Volume	661,535
Z Score	1.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EYPT pay a dividend?

Capital-return profile for this ticker.

Performance

EYPT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EYPT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+71.1%

Float: +69.2% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EYPT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.4

Neutral momentum band

Price vs 200-day MA

-1.3%

50/200-day relationship not available

Beta (5Y)

1.77

More volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EYPT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EYPT stock rating?

EyePoint, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EYPT analysis?

The full report lives at /stocks/EYPT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EYPT?

The latest report frames EYPT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EYPT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.